These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3417974)

  • 1. Use of intravenous amiodarone for emergency treatment of life-threatening ventricular arrhythmias.
    Helmy I; Herre JM; Gee G; Sharkey H; Malone P; Sauve MJ; Griffin JC; Scheinman MM
    J Am Coll Cardiol; 1988 Oct; 12(4):1015-22. PubMed ID: 3417974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous amiodarone in the treatment of refractory life-threatening cardiac arrhythmias in the critically ill patient.
    Leak D
    Am Heart J; 1986 Mar; 111(3):456-62. PubMed ID: 3953353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerance of high-dose intravenous amiodarone for recurrent, refractory ventricular tachycardia.
    Mooss AN; Mohiuddin SM; Hee TT; Esterbrooks DJ; Hilleman DE; Rovang KS; Sketch MH
    Am J Cardiol; 1990 Mar; 65(9):609-14. PubMed ID: 2178383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amiodarone in patients with previous drug-mediated torsade de pointes. Long-term safety and efficacy.
    Mattioni TA; Zheutlin TA; Sarmiento JJ; Parker M; Lesch M; Kehoe RF
    Ann Intern Med; 1989 Oct; 111(7):574-80. PubMed ID: 2774388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term results of amiodarone therapy in patients with recurrent sustained ventricular tachycardia or ventricular fibrillation.
    Herre JM; Sauve MJ; Malone P; Griffin JC; Helmy I; Langberg JJ; Goldberg H; Scheinman MM
    J Am Coll Cardiol; 1989 Feb; 13(2):442-9. PubMed ID: 2913120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term efficacy, safety and survival of patients with potentially lethal ventricular arrhythmias treated with low-dose amiodarone.
    Kerin NZ; Rubenfire M; Blevins RD; Frumin H; Faitel K; Jarandilla R; Aragon E; Marinescu G; Luarca R
    Clin Cardiol; 1988 Mar; 11(3 Suppl 2):II31-40. PubMed ID: 3271193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amiodarone therapy in symptomatic, sustained refractory atrial and ventricular tachyarrhythmias.
    Podrid PJ; Lown B
    Am Heart J; 1981 Apr; 101(4):374-9. PubMed ID: 7211665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term low-dose amiodarone therapy in the management of ventricular and supraventricular tachyarrhythmias: efficacy and safety.
    Lee KL; Tai YT
    Clin Cardiol; 1997 Apr; 20(4):372-7. PubMed ID: 9098598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxic and therapeutic effects of amiodarone in the treatment of cardiac arrhythmias.
    Greene HL; Graham EL; Werner JA; Sears GK; Gross BW; Gorham JP; Kudenchuk PJ; Trobaugh GB
    J Am Coll Cardiol; 1983 Dec; 2(6):1114-28. PubMed ID: 6685151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of amiodarone therapy in the treatment of drug-resistant cardiac arrhythmias: long term follow-up.
    Peter T; Hamer A; Mandel WJ
    Eur Heart J; 1985 Nov; 6 Suppl D():151-62. PubMed ID: 4085515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amiodarone-induced torsades de pointes.
    Brown MA; Smith WM; Lubbe WF; Norris RM
    Eur Heart J; 1986 Mar; 7(3):234-9. PubMed ID: 3709557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous amiodarone used alone or in combination with digoxin for life-threatening supraventricular tachyarrhythmia in neonates and small infants.
    Dilber E; Mutlu M; Dilber B; Aslan Y; Gedik Y; Celiker A
    Pediatr Emerg Care; 2010 Feb; 26(2):82-4. PubMed ID: 20093999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amiodarone in refractory life-threatening ventricular arrhythmias.
    Nademanee K; Singh BN; Hendrickson J; Intarachot V; Lopez B; Feld G; Cannom DS; Weiss JL
    Ann Intern Med; 1983 May; 98(5 Pt 1):577-84. PubMed ID: 6846970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacy of amiodarone in treatment of recurrent ventricular tachycardia and ventricular fibrillation.
    Heger JJ; Prystowsky EN; Zipes DP
    Am Heart J; 1983 Oct; 106(4 Pt 2):887-94. PubMed ID: 6613835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antiarrhythmic therapy in patients with heart failure].
    Faber TS; Zehender M
    Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous amiodarone for recurrent sustained hypotensive ventricular tachyarrhythmias. Intravenous Amiodarone Multicenter Trial Group.
    Levine JH; Massumi A; Scheinman MM; Winkle RA; Platia EV; Chilson DA; Gomes A; Woosley RL
    J Am Coll Cardiol; 1996 Jan; 27(1):67-75. PubMed ID: 8522712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amiodarone in patients with recurrent sustained ventricular tachyarrhythmias: results of programmed electrical stimulation and long-term clinical outcome in chronic treatment.
    Schmitt C; Brachmann J; Waldecker B; Rizos I; Senges J; Kübler W
    Am Heart J; 1987 Aug; 114(2):279-83. PubMed ID: 3604883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five-year follow-up of 589 patients treated with amiodarone.
    Weinberg BA; Miles WM; Klein LS; Bolander JE; Dusman RE; Stanton MS; Heger JJ; Langefeld C; Zipes DP
    Am Heart J; 1993 Jan; 125(1):109-20. PubMed ID: 8417505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amiodarone treatment in patients with ventricular arrhythmias.
    Prystowsky EN; Heger JJ; Miles WM; Zipes DP
    Drugs; 1985 Mar; 29 Suppl 3():47-52. PubMed ID: 3996245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacokinetics and efficacy of amiodarone for refractory tachyarrhythmias.
    Haffajee CI; Love JC; Canada AT; Lesko LJ; Asdourian G; Alpert JS
    Circulation; 1983 Jun; 67(6):1347-55. PubMed ID: 6851030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.